CU6 0.68% $5.89 clarity pharmaceuticals ltd

Research/Valuation, page-176

  1. 1,957 Posts.
    lightbulb Created with Sketch. 325
    The possibility has been discussed, but I've only found two studies that have determined CKD risk.

    https://academic.oup.com/ckj/article/13/6/1049/5549858

    https://www.sciencedirect.com/science/article/abs/pii/S0302283822024010

    the second article has indicated that the cumulative dosage e was >50GBq for the 3 cases with renal damage.

    are there article of studies you can direct me to further to determine this?

    177lu dotate seems to have more risk?

    https://jnm.snmjournals.org/content/63/10/1503
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
(20min delay)
Last
$5.89
Change
0.040(0.68%)
Mkt cap ! $1.835B
Open High Low Value Volume
$5.98 $6.08 $5.74 $6.370M 1.086M

Buyers (Bids)

No. Vol. Price($)
1 3474 $5.89
 

Sellers (Offers)

Price($) Vol. No.
$5.90 825 1
View Market Depth
Last trade - 16.10pm 17/07/2024 (20 minute delay) ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.